{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:10:10Z","timestamp":1781766610057,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.tube.2022.102198","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T03:02:30Z","timestamp":1647572550000},"page":"102198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis"],"prefix":"10.1016","volume":"134","author":[{"given":"Reena","family":"Bharti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.V. Siva","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasham","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampita","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav N.","family":"Mugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-0694","authenticated-orcid":false,"given":"Amit","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tube.2022.102198_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-2600(20)30078-3","article-title":"Host-directed therapies and holistic care for tuberculosis","volume":"8","author":"Zumla","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2022.102198_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-065X.2000.17810.x","article-title":"Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion","volume":"178","author":"Dupuis","year":"2000","journal-title":"Immunol Rev"},{"issue":"6\u20137","key":"10.1016\/j.tube.2022.102198_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00439-020-02126-6","article-title":"The monogenic basis of human tuberculosis","volume":"139","author":"Boisson-Dupuis","year":"2020","journal-title":"Hum Genet"},{"issue":"9064","key":"10.1016\/j.tube.2022.102198_bib4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(96)12273-X","article-title":"Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol","volume":"349","author":"Condos","year":"1997","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.tube.2022.102198_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006984","article-title":"Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis","volume":"4","author":"Dawson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102198_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2018.06.004","article-title":"Repurposing of gamma interferon via inhalation delivery","volume":"133","author":"Smaldone","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.tube.2022.102198_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40268-020-00321-4","article-title":"Comparability considerations and challenges for expedited development programs for biological products","volume":"20","author":"Schrieber","year":"2020","journal-title":"Drugs R"},{"issue":"11","key":"10.1016\/j.tube.2022.102198_bib8","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/S1470-2045(16)30374-6","article-title":"Safety and efficacy of biosimilars in oncology","volume":"17","author":"Schellekens","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tube.2022.102198_bib9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.omtn.2020.10.023","article-title":"Transient transfection of the respiratory epithelium with gamma interferon for host-directed therapy in pulmonary tuberculosis","volume":"22","author":"Bharti","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.tube.2022.102198_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.addr.2016.01.016","article-title":"Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis","volume":"102","author":"Gupta","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tube.2022.102198_bib11","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.btecx.2019.100007","article-title":"Small-scale GMP production of plasmid DNA using a simplified and fully disposable production method","volume":"2","author":"Bakker","year":"2019","journal-title":"J Biotechnol X"},{"issue":"1","key":"10.1016\/j.tube.2022.102198_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2008.02.008","article-title":"A hand-held apparatus for \"nose-only\" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages","volume":"34","author":"Kaur","year":"2008","journal-title":"Eur J Pharmaceut Sci"},{"issue":"9871","key":"10.1016\/j.tube.2022.102198_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tube.2022.102198_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jit555","article-title":"Lack of a therapeutic role for interferon \u03b3 in patients with tuberculosis","volume":"209","author":"Wallis","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2022.102198_bib15","doi-asserted-by":"crossref","unstructured":"J. Grosset, \"Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary,\" Antimicrob Agents Chemother, vol. 47, no. 3, pp. 833-836, doi: 10.1128\/aac.47.3.833-836.2003.","DOI":"10.1128\/AAC.47.3.833-836.2003"},{"issue":"3","key":"10.1016\/j.tube.2022.102198_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0024-2016","article-title":"Mycobacterial biofilms: revisiting tuberculosis bacilli in extracellular necrotizing lesions","volume":"5","author":"Basaraba","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"12","key":"10.1016\/j.tube.2022.102198_bib17","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.4049\/jimmunol.1200255","article-title":"Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis","volume":"188","author":"Desvignes","year":"2012","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.tube.2022.102198_bib18","doi-asserted-by":"crossref","first-page":"e01514","DOI":"10.1128\/mBio.01514-17","article-title":"Role of granulocyte-macrophage colony-stimulating factor production by T cells during Mycobacterium tuberculosis infection","volume":"8","author":"Rothchild","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.tube.2022.102198_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fmicb.2020.01643","article-title":"Susceptibility to intracellular infections: contributions of TNF to immune defense","volume":"11","author":"Li","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102198_bib20","doi-asserted-by":"crossref","unstructured":"S. A. Khader et al., \"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge,\" Nat Immunol, vol. 8, no. 4, pp. 369-377, doi: 10.1038\/ni1449.","DOI":"10.1038\/ni1449"},{"issue":"7","key":"10.1016\/j.tube.2022.102198_bib21","doi-asserted-by":"crossref","first-page":"e1002196","DOI":"10.1371\/journal.ppat.1002196","article-title":"What do we really know about how CD4 T cells control Mycobacterium tuberculosis?","volume":"7","author":"Torrado","year":"2011","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.tube.2022.102198_bib22","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.tube.2022.102198_bib23","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.cell.2021.02.046","article-title":"A non-canonical type 2 immune response coordinates tuberculous granuloma formation and epithelialization","volume":"184","author":"Cronan","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tube.2022.102198_bib24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acs.molpharmaceut.6b01089","article-title":"Pharmacokinetics, metabolism, and partial biodistribution of \"pincer therapeutic\" nitazoxanide in mice following pulmonary delivery of inhalable particles","volume":"14","author":"Gupta","year":"2017","journal-title":"Mol Pharm"},{"issue":"17","key":"10.1016\/j.tube.2022.102198_bib25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2174\/1381612822666160128150636","article-title":"Opportunities and challenges for host-directed therapies in tuberculosis","volume":"22","author":"Sachan","year":"2016","journal-title":"Curr Pharmaceut Des"},{"issue":"8","key":"10.1016\/j.tube.2022.102198_bib26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s11095-016-1926-0","article-title":"Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy","volume":"33","author":"Gupta","year":"2016","journal-title":"Pharmaceut Res"},{"key":"10.1016\/j.tube.2022.102198_bib27","doi-asserted-by":"crossref","unstructured":"A. Gupta, G. Pant, K. Mitra, J. Madan, M. K. Chourasia, and A. Misra, \"Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis,\" Mol Pharm, vol. 11, no. 4, pp. 1201-1207, Apr 7 2014, doi: 10.1021\/mp4006563.","DOI":"10.1021\/mp4006563"},{"issue":"5","key":"10.1016\/j.tube.2022.102198_bib28","first-page":"479","article-title":"Open source drug discovery\u2013a new paradigm of collaborative research in tuberculosis drug development","volume":"91","author":"Bhardwaj","year":"2011","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.tube.2022.102198_bib29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.drudis.2018.01.009","article-title":"On the glycosylation aspects of biosimilarity","volume":"23","author":"Hajba","year":"2018","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.tube.2022.102198_bib30","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jth.12629","article-title":"Biosimilars: the process is the product. The example of recombinant streptokinase","volume":"12","author":"Thelwell","year":"2014","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.tube.2022.102198_bib31","first-page":"433","article-title":"Biosimilar gene therapy: investigational assessment of secukinumab gene therapy","volume":"21","author":"Fallah","year":"2020","journal-title":"Cell J."},{"issue":"11","key":"10.1016\/j.tube.2022.102198_bib32","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.tube.2022.102198_bib33","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1152\/japplphysiol.01322.2009","article-title":"Lung structure phenotype variation in inbred mouse strains revealed through in vivo micro-CT imaging","volume":"109","author":"Thiesse","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.tube.2022.102198_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1573-4285(05)80006-7","article-title":"Chapter 2 Morphometry of the human respiratory system","volume":"5","year":"2005","journal-title":"Inteerf. Sci. Technol."},{"issue":"5","key":"10.1016\/j.tube.2022.102198_bib35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/ijmr.IJMR_554_18","article-title":"Animal models of tuberculosis: lesson learnt","volume":"147","author":"Singh","year":"2018","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2022.102198_bib36","doi-asserted-by":"crossref","first-page":"102081","DOI":"10.1016\/j.tube.2021.102081","article-title":"Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month","volume":"128","author":"Singh","year":"2021","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.tube.2022.102198_bib37","first-page":"166","article-title":"Why wait?","volume":"36","author":"Braunstein","year":"2019","journal-title":"Case Treat. Tubercul. Inhaled Drugs"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922200035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922200035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:45:47Z","timestamp":1761468347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297922200035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"alternative-id":["S147297922200035X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2022.102198","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2022.102198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102198"}}